Sai Life Sciences Ltd
05 Oct 2026 12:00 AM
Sai Life Sciences reported securities dematerialization details to Indian stock exchanges,
Sai Life Sciences Limited informed the National Stock Exchange of India Limited and the BSE Limited that it has certified the details of securities dematerialized/rematerialized during the quarter ended September 30, 2026, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, and furnished them to all stock exchanges where the company is listed, according to a filing on October 5, 2026. KFin Technologies Limited acted as the Registrar to an Issue and Share Transfer Agent for Sai Life Sciences Limited.
Sai Life Sciences Ltd
01 Oct 2026 12:00 AM
Sai Life Sciences to review financial results at board meeting on November 5, 2026,
Sai Life Sciences Limited will hold a board meeting on Thursday, November 5, 2026, to consider and approve the standalone and consolidated unaudited financial results for the second quarter and half year ended September 30, 2026, as well as other corporate matters. The trading window for the company`s securities was closed for designated persons and their immediate relatives from October 1, 2026, and will remain closed until November 7, 2026.
Sai Life Sciences Ltd
28 Sep 2026 12:00 AM
Sai Life Sciences halts securities trading ahead of Q2/H1 2026 results announcement,
Sai Life Sciences Limited will close its trading window for securities from October 1, 2026, until 48 hours after the announcement of its unaudited financial results for the second quarter and half year ending September 30, 2026, in compliance with SEBI’s Prohibition of Insider Trading Regulations and the company’s Code of Conduct.
Sai Life Sciences Ltd
18 Sep 2026 12:00 AM
Sai Life Sciences allotted equity shares under its 2008 plan, increasing capital,
Sai Life Sciences Limited announced the allotment of 24,000 fully paid-up equity shares with a face value of Rs 1 each under its Employees Stock Option Plan 2008, according to a regulatory filing on September 18, 2026. The allotment increased the company`s issued, subscribed, and paid-up equity share capital from Rs 21,23,94,217 to Rs 21,24,18,216.
Sai Life Sciences Ltd
01 Sep 2026 12:00 AM
Sai Life Sciences allotted shares under two employee stock option plans, increasing equity capital,
Sai Life Sciences Limited announced the allotment of 14,600 shares under the Employees Stock Option Plan 2008 and 66,000 shares under the Management Employee Stock Option Plan 2018, increasing the company’s issued, subscribed, and paid-up equity share capital from Rs 21,23,13,617 to Rs 21,23,94,216. The exercise price was Rs 188.90 per share for the ESOP 2008 allotment and Rs 23.30 per share for the MESOP 2018 allotment, with a premium of Rs 187.90 and Rs 22.30 respectively.
Subscribe for our
newsletter
newsletter
HSL Mobile App